Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Primary Biliary Cholangitis
Related studies linked through entity extraction aliases.
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
- Status
- RECRUITING
- Phase
- PHASE4
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
- Status
- COMPLETED
- Phase
- PHASE3
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
- Status
- UNKNOWN
- Phase
- PHASE4
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
- Status
- UNKNOWN
- Phase
- PHASE4
Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
- Status
- COMPLETED
- Phase
- PHASE2
Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC
- Status
- TERMINATED
- Phase
- PHASE2
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study
- Status
- TERMINATED
- Phase
- NA
Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis
- Status
- UNKNOWN
- Phase
- N/A
Combination Antiretroviral Therapy (cART) for PBC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
- Status
- TERMINATED
- Phase
- PHASE2
A Post-Authorisation Non-Interventional Observational of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real Life
- Status
- UNKNOWN
- Phase
- N/A
Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis
- Status
- TERMINATED
- Phase
- NA
ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
- Status
- COMPLETED
- Phase
- PHASE3
Early Identification of Myocardial Impairment in PBC
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
- Status
- COMPLETED
- Phase
- PHASE2